|
|
|
- ともあき ふじつぐ
- 9 years ago
- Views:
Transcription
1
2
3 -1 -
4 -2 -
5 -3 -
6 -4 -
7 -5 -
8 -6 -
9 -7 -
10 -8 -
11 -9 -
12 - 10 -
13 -11 -
14 - 12 -
15 - 13 -
16 - 14 -
17 - 15 -
18 - 16 -
19 - 17 -
20 - 18 -
21 - 19 -
22 - 20 -
23 - 21 -
24 - 22 -
25 - 23 -
26 - 24 -
27 - 25 -
28 - 26 -
29 - 27 -
30 - 28 -
31 - 29 -
32 - 30 -
33 - 31 -
34 - 32 -
35 - 33 -
36 - 34 -
37 - 35 -
38 - 36 -
39 - 37 -
40 - 38 -
41 - 39 -
42 - 40 -
43 - 41 -
44 - 42 -
45 - 43 -
46 17 RI 16 H16.3 H12.10 H8.4 S54.4 H15.4 H12.4 H17.5 H12.12 H16.9 H17.4 H17.4 H17.5 H17.10 H18.2 DNA PCRDNA MALDI-TOF/TOF
47 DNA
48 2 (2005 )
49 - 47 -
50 - 48 -
51 - 49 -
52 - 50 -
53 - 51 -
54 - 52 -
55 - 53 -
56 RI Jr
57
58 - 56 -
59 ; 600 ; DNA Zeiss Beckman Beckman TOMY Beckman BIORAD GenePulser CCD Zeiss CCD Zeiss Zeiss Lumat BIORAD PDS-1000DNA ABI373AABI310ABI3100 Procise clc GE Typhoon Affimetrix Becton DickinsonHPLC
60 1 FACS FACS 1FACS Calibur 2 3 2RI RI
61 - 59 -
62
63 - 61 -
64 - 62 -
65 - 63 -
66 - 64 -
67 - 65 -
68 - 66 -
69 - 67 -
70 - 68 -
71 - 69 -
72 - 70 -
73 - 71 -
74 - 72 -
75 - 73 -
76 RI RI
77 RNA in vitro RNA I sirna CYP3A H The Replication Fork Protection Complex Drexel University College of Medicine H H H Vibrio furnissii Vibrio cholerae Rochester
78 Gateway DNA l ND1000 Miniscope TM1000 DNA BZ8000 ZOOM IPG SSH
79 DNA 1 I
80 DNA 1,753 m 2 RI RI P1 P2 P3 DNA 233 DNA RI MRC DNA Dr. David Loakes (MRC, Laboratory of Molecular Biology, Cambridge, UK)
81 DNA DNA DNA SSP 40 in vitro DNA II III MATE DNA
82 RI DNA 15 DNA 2 DNA DNA
83 CCD ( ) ( )
84 GeneChip technology ( ) DNA DNA PCR 4.RNA 5.RT-PCR 6. 7.DNA ( ) (1) (2) DNA (3) DNA (1) (2) DNA (3)
85 ( ) D Jr. 1 2 DNA 3RFLP 4PCR 5 DNA 6RT-PCR ( )
86 DNA
87 - 85 -
88 Hara, K., Okamoto, M., Aki, T., Yagita, H., Tanaka, H., Mizukami, Y., Nakamura, H., Tomoda, A., Hamasaki, N., Kang, D., Synergistic enhancement of TRIL- and tumor necrosis factor a-induced cell death by a phenoxazine derivative, Mol. Cancer Ther.4 (7), (2005) Aki, T., and Mizukami, Y., Regulation of Cardiomyocyte functions by distinct phosphoinositide 3-kinase, Molecular Mechanisms of Heart diseases, (Edits Mizukami, Y. and Ohkusa, T.) Publisher Research Signport, (2005) Kimura, Y, and Mizukami, Y.,and Matsuzaki, M., Orphan G protein-coupled receptor and ischemia, Molecular Mechanisms of Heart diseases, (Edits Mizukami, Y. and Ohkusa, T.) Publisher Research Signport, (2005)
89 - 87 -
90 - 88 -
91 - 89 -
92 - 90 -
93 - 91 -
94 - 92 -
95 - 93 -
96 RI DNA P2 P3 DNA DNA DNA DNA C TOF-MS 3130 Avant
97 in DNA type III
98 - 96 -
99 - 97 -
100 - 98 -
101 - 99 -
102
103
104
105
106 IV
107
108
109
110
111
112
113 FSRC 2 ( ) RNA P3 DNA 4 1 RI -80 CCD TOF PCR [450 ] /
114 DNA DNA / /1 370 PCR46 TOF DNA L5 FL () 8 4 DNA (3 ) (9 )
115
116
117
118
119
120
44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
i
14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7
橡NO005-PDF用.ec5
(Biotechnology, Cell Biology, Genetics, Immunology, Medicine, Neuroscience, Structural Biology) (Cancer, Genetics, Immunology, Molecular Cell Biology, Neuroscience) InfoPort TEL: 043-290-2262 FAX:
- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
第124回日本医学会シンポジウム
III γ γ γ α γ Molecular Mechanism of Insulin Resistance by Adipocytes TAKASHI KADOWAKI Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo Key words γ 110 124 TNFα FFA 1,2
1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
provider_020524_2.PDF
1 1 1 2 2 3 (1) 3 (2) 4 (3) 6 7 7 (1) 8 (2) 21 26 27 27 27 28 31 32 32 36 1 1 2 2 (1) 3 3 4 45 (2) 6 7 5 (3) 6 7 8 (1) ii iii iv 8 * 9 10 11 9 12 10 13 14 15 11 16 17 12 13 18 19 20 (2) 14 21 22 23 24
「産業上利用することができる発明」の審査の運用指針（案）
1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)
178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21
I 178 II 180 III ( ) 181 IV 183 V 185 VI 186 178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 4 10 (
CRS4
I... 1 II... 1 A... 1 B... 1 C... 1 D... 2 E... 3 III... 3 A... 3 B... 4 C... 5 IV... 8 A... 8 B... 8 C... 9 D... 10 V... 11 A... 11 B... 11 C... 12 VI... 12 A... 12 B... 12 C... 12 VII... 13 ii I II A
untitled
i ii iii iv v 43 43 vi 43 vii T+1 T+2 1 viii 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 a) ( ) b) ( ) 51
AccessflÌfl—−ÇŠš1
ACCESS ACCESS i ii ACCESS iii iv ACCESS v vi ACCESS CONTENTS ACCESS CONTENTS ACCESS 1 ACCESS 1 2 ACCESS 3 1 4 ACCESS 5 1 6 ACCESS 7 1 8 9 ACCESS 10 1 ACCESS 11 1 12 ACCESS 13 1 14 ACCESS 15 1 v 16 ACCESS
2
1 2 3 4 5 6 7 8 9 10 I II III 11 IV 12 V 13 VI VII 14 VIII. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 _ 33 _ 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 VII 51 52 53 54 55 56 57 58 59
262014 3 1 1 6 3 2 198810 2/ 198810 2 1 3 4 http://www.pref.hiroshima.lg.jp/site/monjokan/ 1... 1... 1... 2... 2... 4... 5... 9... 9... 10... 10... 10... 10... 13 2... 13 3... 15... 15... 15... 16 4...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 () - 1 - - 2 - - 3 - - 4 - - 5 - 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
\n Title 05 実 験 展 示 の 実 施 記 録 Author(s) 中 村, ひろ 子 ; NAKAMURA, Hiroko Citation 実 験 展 示 あるく 身 体 の 記 憶 をつくる: 24-61 Date 2008-03-20 Type Research Paper Rights publisher KANAGAWA University Repository 27 28
- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...
取 扱 説 明 書 - - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...9...11 - - - - - - - - - - - - - - - - -
ito.dvi
1 2 1006 214 542 160 120 160 1 1916 49 1710 55 1716 1 2 1995 1 2 3 4 2 3 1950 1973 1969 1989 1 4 3 3.1 3.1.1 1989 2 3.1.2 214 542 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
入門ガイド
ii iii iv NEC Corporation 1998 v P A R 1 P A R 2 P A R 3 T T T vi P A R T 4 P A R T 5 P A R T 6 P A R T 7 vii 1P A R T 1 2 2 1 3 1 4 1 1 5 2 3 6 4 1 7 1 2 3 8 1 1 2 3 9 1 2 10 1 1 2 11 3 12 1 2 1 3 4 13
SC-85X2取説
I II III IV V VI .................. VII VIII IX X 1-1 1-2 1-3 1-4 ( ) 1-5 1-6 2-1 2-2 3-1 3-2 3-3 8 3-4 3-5 3-6 3-7 ) ) - - 3-8 3-9 4-1 4-2 4-3 4-4 4-5 4-6 5-1 5-2 5-3 5-4 5-5 5-6 5-7 5-8 5-9 5-10 5-11
<4D6963726F736F667420506F776572506F696E74202D208376838C835B83938365815B835683878393312E707074205B8CDD8AB78382815B83685D>
i i vi ii iii iv v vi vii viii ix 2 3 4 5 6 7 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
![表紙07 [更新済み]](/thumbs/43/23111104.jpg "表紙07 [更新済み]")
（個別のテーマ） 薬剤に関連した医療事故
- 67 - III - 68 - - 69 - III - 70 - - 71 - III - 72 - - 73 - III - 74 - - 75 - III - 76 - - 77 - III - 78 - - 79 - III - 80 - - 81 - III - 82 - - 83 - III - 84 - - 85 - - 86 - III - 87 - III - 88 - - 89
（個別のテーマ） 放射線検査に関連した医療事故
- 131 - III - 132 - - 133 - III - 134 - - 135 - III - 136 - - 137 - III - 138 - - 139 - III - 140 - - 141 - III - 142 - - 143 - III - 144 - - 145 - III - 146 - - 147 - III - 148 - - 149 - III - 150 - -
![.V...z.\](/thumbs/40/20575037.jpg ".V...z.\")
3 6 6 8 5 5 0 4 3 4 4 0,000 3 ID ID ID 4 7 9 :5 4 5 60-8048 NACOS TEL: 075-45-366 FAX: 075-45-366 E-mail: [email protected] 3. Power Point PC 0 5. Power Point PC 7 3 3. 3 5 PC PC PC Windows Power Point USB
The Molecular Biology Society of Japan MBSJ NEWS 2013.11 No.106 http://www.mbsj.jp/ 2020 2020 7 2009 4 1 3 2011 1 3 1 2020 XLab 2 3 4 5 XLabExperiment, experience, exciting, expert Eva-Maria Neher 20
EV200R I II III 1 2 3 4 5 6 7 8 9 10 1 2 3 11 4 5 12 6 13 1 2 14 3 4 15 5 16 1 2 17 3 18 4 5 19 6 20 21 22 123 456 123 456 23 1 2 24 3 4 25 5 3 26 4 5 6 27 7 8 9 28 29 30 31 32 1 2 33 3 4 34 1 35 2 1
これわかWord2010_第1部_100710.indd
i 1 1 2 3 6 6 7 8 10 10 11 12 12 12 13 2 15 15 16 17 17 18 19 20 20 21 ii CONTENTS 25 26 26 28 28 29 30 30 31 32 35 35 35 36 37 40 42 44 44 45 46 49 50 50 51 iii 52 52 52 53 55 56 56 57 58 58 60 60 iv
パワポカバー入稿用.indd
i 1 1 2 2 3 3 4 4 4 5 7 8 8 9 9 10 11 13 14 15 16 17 19 ii CONTENTS 2 21 21 22 25 26 32 37 38 39 39 41 41 43 43 43 44 45 46 47 47 49 52 54 56 56 iii 57 59 62 64 64 66 67 68 71 72 72 73 74 74 77 79 81 84
これでわかるAccess2010
i 1 1 1 2 2 2 3 4 4 5 6 7 7 9 10 11 12 13 14 15 17 ii CONTENTS 2 19 19 20 23 24 25 25 26 29 29 31 31 33 35 36 36 39 39 41 44 45 46 48 iii 50 50 52 54 55 57 57 59 61 63 64 66 66 67 70 70 73 74 74 77 77
ÿþ
I O 01 II O III IV 02 II O 03 II O III IV III IV 04 II O III IV III IV 05 II O III IV 06 III O 07 III O 08 III 09 O III O 10 IV O 11 IV O 12 V O 13 V O 14 V O 15 O ( - ) ( - ) 16 本 校 志 望 の 理 由 入 学 後 の
計算機生命科学の基礎II_
Ⅱ 1.4 [email protected] 812-8582 3-1-1 8 806 http://www.cell-innovator.com BioGPS Connectivity Map The Cancer Genome Atlas (TCGA); cbioportal GO DAVID, GSEA WCGNA BioGPS http://biogps.org/
untitled
2015 2004 6 22 (1) 2 3 4 50 550 2 80 10 3 100 10 165 50 1,000 2223 2 6,800 8,400 5001,000 23 () 5 1 1 02 04 5,400 3 46 80 90 70 7090 610 02 18.2 05 22.6 1120 3,000 30 5 90 15 90 22.8 1015 80 90 1120
広報えちぜん12月号_4校.indd
24 7,140,000 24 3,129,000 24 20,685,000 24 9,292,500 24 8,925,000 24 13,492,500 24 NO. 5,670,000 24 4,470,900 24 8,494,500 24 2,341,500 24 4,021,500 Jr. [ ] 128 1214 845 855 1345 1355 2015 2025 121 127
2 3 4 5 6 7 8 ( ) 9 10 11 12 13 14 S JR 16 22 23 24 25 27 29 30 31 32 33 34 35 36 37 38 39 40 41 JR JR 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72
report_c.ai
39 182646163205 40 41 42 43 44 45 46 47 48 49 ( 50 1 2 1 P.4 2 P.5 51 50 20 52 3 4 3 P.4 4 P.5 53 JR 10 54 5 6 5 P.4 6 P.5 55 20 20 510 26 46 56 26 57 ( 510 58 26 59 ( 40 = 510 60 26 26 61 ( ( ( ) 10 62